dimethyl fumarate mylan
mylan ireland limited - fumarato de dimetilo - esclerose múltipla remitente-recorrente envio - imunossupressores - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - fumarato de dimetilo - esclerose múltipla remitente-recorrente envio - imunossupressores - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate teva
teva gmbh - fumarato de dimetilo - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunossupressores - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - fumarato de dimetilo - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunossupressores - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - fumarato de dimetilo - esclerose múltipla remitente-recorrente envio - imunossupressores - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera
biogen netherlands b.v. - fumarato de dimetilo - esclerose múltipla - imunossupressores - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
skilarence
almirall s.a - fumarato de dimetilo - psoríase - imunossupressores - skilarence é indicado para o tratamento da psoríase em placas moderada a grave em adultos com necessidade de terapia medicamentosa sistêmica.
imipenem + cilastatina elc 500 mg + 500 mg pó para solução para perfusão
elc group, s.r.o. - imipenem + cilastatina - pó para solução para perfusão - 500 mg + 500 mg - imipenem mono-hidratado 530 mg ; cilastatina sódica 532 mg - imipenem and cilastatin - genérico - duração do tratamento: curta ou média duração